jump to content jump to footer

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion categories, and evaluate responses. Track key measurements like diameter, volume, SUV, and ADC, ensuring compliance with required minimum sizes. Automate sum calculations for response determination and integrate clinical data such as ctDNA or PSA values. Document multiple lesions, compare absolute and relative changes over time, and visualize trends with interactive charts. Generate comprehensive reports with tables and graphs for a clear longitudinal overview.

Key features:

  • Easily customizable parameters
    • Questions for manual response evaluation
    • Lesion categories (e.g., target lesions, non-target lesions)
    • System-derived lesion states (e.g., normalized for lymph nodes)
    • Key measurement values (e.g., longest diameter, short axis, volume, SUV, ADC, etc.), including required minimum size for each lesion category
    • Sum of measurements for response determination (e.g., sum of diameter or sum of volume)
    • Clinical data (e.g., ctDNA or PSA values)
  • Ability to document the count of multiple (non-target and new) lesions
  • Automatic calculations of absolute and relative differences to baseline, previous timepoint and nadir
  • Interactive charts displaying all relevant values over time, including clinical data, with dynamic filtering options
  • Comprehensive reports including tables and graphs for a fast and clear longitudinal overview
Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Read more
Onur Özek from Mint Medical discusses the challenges, requirements, and future of lung cancer screening in Germany in an interview with RadMag.
In the latest RadMag Special Edition, Onur Özek discusses structured reporting, AI integration, second-reader workflows, interoperability, and the importance of end-to-end workflow management for lung cancer.
RadMag Special Edition: Onur Özek on the Challenges of Lung Cancer Screening in Germany
With the nationwide rollout of Germany’s lung cancer screening, radiology providers are facing new challenges. Structured reporting, mandatory second…
Read more
Mint Medical and Coreline teams coming together to announce partnership
Mint Medical and Coreline Soft integrate AVIEW into mint Lesion to support AI-enabled workflows for structured reporting, Lung-RADS assessment, and longitudinal nodule management in lung cancer screening.
Coreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer Screening
Coreline Soft and Mint Medical today announced a partnership to advance AI-enabled lung cancer screening, following more than six months of technical…
Read more
scroll-top